Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Glucose + Sodium chloride + Sodium citrate
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Glucose + Sodium chloride + Sodium citrate on the MHRA register
Oral Rehydration Salts potassium free powder sachets (Queens Hospital Burton formula)
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 2 · Randomised trials: 1 · 1998–2026
Showing the 50 most relevant studies, sorted by most relevant.
Tsuang FY, Wu YL, Chan KC, et al.
2026
- Lumbar Vertebrae
- Acidosis
- Fluid Therapy
IntroductionIntravenous crystalloid fluid infusion is a mandatory nutritional intervention received by surgical patients. Crystalloids vary in the pH value and electrolyte balance when administered; these effects directly alter plasma and urine compositions and can considerably affect the patient's intraoperative metabolism.MethodsThis randomized controlled study compared 0.9% saline solution and lactated Ringer's solution in terms of intraoperative metabolism among 56 patients undergoing lumbar spinal surgery. Blood and urine samples were obtained before and after surgery for arterial blood gas analysis and untargeted metabolomic analysis using liquid chromatography-mass spectrometry.ResultsPatients receiving 0.9% saline developed hyperchloremic acidosis and exhibited higher postoperative plasma concentrations of sodium (interaction P = 0.008) and glucose (interaction P = 0.034). They also required higher intraoperative norepinephrine doses (18 [0-43] μg vs. 0 [0-5] μg; P P = .051); significantly higher oxaloacetate concentrations (interaction P = .015), which may indicate less intraoperative gluconeogenesis (interaction P = .015); lower leucine degradation metabolite concentration, namely hydroxyisocaproic acid (interaction P = .055); and an attenuated decline in anti-inflammatory phospholipid breakdown metabolite, namely 15-ketoeicosatetraenoic acid (interaction P = .063). By contrast, patients receiving 0.9% saline solution exhibited unfavorable metabolism in urine indicated by reduced excretion of citric acid and creatine, which correlated with reduced glomerular filtration rates.ConclusionsThe administration of lactated Ringer's solution may facilitate more favorable intraoperative metabolic profiles than the administration of 0.9% saline solution during lumbar spinal surgery.
Abstract licence: CC BY-NC
Lorente JV, Hervías Sanz M, Ripollés-Melchor J, et al.
2025
Intravenous fluid administration is an important part of the management of the surgical patient. Fluid can be used to compensate for the normal turnover of fluid and electrolytes (maintenance), to replace losses, to expand the extracellular fluid space to maintain adequate circulation (resuscitation), and to provide nutrition. Too little fluid and too much fluid both increase the number of postoperative complications. Balanced crystalloid solutions, such as buffered Ringer's, Plasma-Lyte®, and Sterofundin®, are the most widely used fluids. Isotonic (0.9%) sodium chloride should be reserved for alkalotic and/or hyponatremic patients. Small amounts of these fluids (3 L). Maintenance fluids contain glucose and are indicated during the postoperative period before oral hydration is possible. Glucose might also be provided when awaiting surgery. The choice of replacement fluid is governed by the type of losses that have occurred. The goal of infusion fluids during hemorrhage or serious disease changes over time and might be described in the four phases resuscitation, optimization, stabilization, and de-resuscitation. Nutrition fluids are indicated after 1 week without adequate oral nutrition. Fluid therapy during surgery is performed according to the fluid balance approach (minor surgery), the outcome-oriented approach (intermediate-size surgery), or the goal-directed approach (major surgery). Children tolerate prolonged fasting poorly and preoperative fasting for clear fluids should not exceed 1 h. They have a greater tendency to develop hypoglycemia and hyponatremia than adults and, therefore, isotonic crystalloids that minimize these risks should be used during pediatric surgery. The basal daily need for fluid is children is usually taken according to the "4-2-1" rule to which additions can be made depending on the extent of the surgery. Intravenous fluid administration should be continued during the postoperative phase until enteral hydration is feasible.
Abstract licence: CC BY
Arzu Ilercil, Richard B. Devereux, Mary J. Roman, et al.
American Heart Journal, 2001
A. C. Ricard, C. Daniel, P. Anderson, et al.
Archives of Environmental Contamination and Toxicology, 1998
Kaikai Gao, H. Wang, Yu Chen, et al.
Bioresource technology, 2023
David A. Weinstein, Michael J.G. Somers, Joseph I. Wolfsdorf
The Journal of Pediatrics, 2001
Xie A, Brunner JS, Chakraborty S, et al.
2026
- Citric Acid
- Aconitate Hydratase
- Citric Acid Cycle
The tricarboxylic acid (TCA) cycle couples nutrient oxidation with the generation of reducing equivalents that power oxidative phosphorylation. Nevertheless, the requirement for components of the TCA cycle is context-specific, raising the question of which TCA cycle outputs support cell fitness. Here, we demonstrate that citrate clearance is an essential function of the TCA cycle. As citrate production increases, so do TCA cycle activity and dependence upon aconitase 2 (ACO2), the enzyme that initiates citrate catabolism in the TCA cycle. Disrupting citrate catabolism activates the integrated stress response and impairs cell fitness, and these effects are reversed by preventing citrate production or promoting mitochondrial citrate efflux. In vivo, ACO2 deficiency induces citrate accumulation and triggers tubular degeneration in the kidney, a tissue that physiologically takes up circulating citrate. Thus, intracellular citrate accumulation can be a metabolic liability, and citrate clearance is a major function of ACO2 in the TCA cycle.
Abstract licence: CC BY-NC-ND
Doyel M. Bhattacharya, S. S. Dhondge, S. Zodape
The Journal of Chemical Thermodynamics, 2016
Ulsamer A, Betbesé AJ, Campos-Gómez A, et al.
2025
- Bicarbonates
- Solutions
- Buffers
There is a widespread belief that organic sodium salts included in intravenous solutions serve as bicarbonate precursors, and that this mechanism explains their effects on plasma pH. We aimed to explain why the effect of organic anions, such as citrate, acetate, gluconate, and lactate on the acid-base balance is independent of bicarbonate generation. For this purpose, we mainly focused on regional citrate anticoagulation (RCA). The sodium load provided with these buffers and its contribution to the plasma strong ion difference is a more suitable model for explaining and predicting their alkalinizing effect. Moreover, the bicarbonate generated from the metabolization of these buffers via the Krebs cycle results from CO2 dissolution in water, and thus yields bicarbonate together with a proton (H+). As such, metabolization of these buffers does not cause alkalosis per se.
Abstract licence: CC BY-NC-ND
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.